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Lepra BonitaAbstract Pretty leprosy is one of the rare severe forms of lepromatous leprosy. It is a reaction pattern
that occurs in untreated pure primitive diffuse lepromatous leprosy or lepromatous leprosy. The skin
of the patient is diffusely inﬁltrated and shiny, so that natural wrinkles are obliterated. It generates a
moist andmyxoedematous complexion imparting a healthy aspect to the patient. Thus the disease got
the name. In this reviewwe have reviewed almost all available literature to pointmore light toward the
clinical variant pretty leprosy. A search wasmade in PubMed central to know the availability of infor-
mation about pretty leprosy, but the response was nil for pretty leprosy. 37 articles were spotted in
PubMed media on Lucioleprosy; 3 review articles are present and the rest were case reports.
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leled historical stigma and fear that has earned the appellation
Kushtha. According to Vagbhata (600 AD), the name ‘‘Kush-
tha’’ was derived from ‘‘Kushnati’’ which means ‘‘eating
away’’ in Sanskrit. The disease leprosy was ﬁrst described
around 600 BC., but the origin is still unknown. Throughout
history, leprosy has been feared and misunderstood, since it
is an important cause of crippling deformities [1]. Leprosy is
one of the oldest diseases of mankind which most probably
originated in India [30]. The laws of Manu, stated in the Vedas
written as early as 1400 BC in India, included instructions for
the prevention of leprosy (Fig. 1).
In 1844 Ladislao de la Pascua described the ‘spotted or laz-
arine leprosy’ [8] for the ﬁrst time. Later on in 1852, Lucio and
Alvarado studied and published it with the same names. It is
actually a clinical variety of lepromatous leprosy [8,9,26].
Latapı´ (1938) re-discovered it and reported with Zamora [26]
(1948), the same as ‘spotted leprosy of Lucio’. Frenken named
it as ‘diffuse leprosy of Lucio and Latapı´’ in 1963 [10]. Latapı´
and Che´vez-Zamora explained that the chief presentation of
this variety of lesion was diffuse generalized cutaneous inﬁltra-
tion (pure and primitive diffuse lepromatosis), upon which
necrotizing lesions develop, calling these lesions ‘Feno´meno
de Lucio or erythema necrotisans’. [10] Shiny [11] myxedoema-
toid appearance of the skin made us call it as Lepra Bonita
(Spanish word), meaning ‘pretty leprosy’ [12,17].
History shows evidence of a debate in 1960–1970s about the
choice of selecting an appropriate name for this disease viz.
leprosy, lepra, Hansen’s disease or Hanseniasis [2–6]. A strong
movement developed in some countries to substitute the name
Hansen’s disease for leprosy [7].
Epidemiology
It is primarily seen in Mexico (23% cases), common in Costa
Rica, one of the Latin American Countries [8,13], Columbia
and Brazil [14] and; less common in gulf coast [15]. But it is
quite rare in the rest of the world. This sort of Hansen disease
was ﬁrst described in Mexico by Doctor Rafael Lucio in 1853Figure 1 Diffuse lepromatous leprosy in late stage. Flaccid skin
in particular that of ear lobe.[16]. A case of lepromatous leprosy with Lucio’s phenomenon
was reported recently in India [31].
Etiopathogenesis
The most accepted pathogenesis for Lucio’s phenomenon is
free replication of M. leprae in endothelial cells and enhanced
exposure of mycobacterial antigen to circulating antibodies,
resulting in vasculitis and infarction. This associated with
inﬂammatory reactions and changes in the coagulation system
causes vascular thrombosis, ischemia and tissue necrosis, lead-
ing to the histopathological features of the phenomenon [32].
Arthrus Phenomenon and Schwartzman Phenomenon are also
suggested by various authors. Intercurrent infections may be a
triggering factor and precipitate the reaction. Several LP trig-
gering factors that have been suggested are streptococcal, cryp-
tococcal, respiratory infections, drugs such as iodide,
chaulmoogra oil and pregnancy [28].Clinical features and manifestations
According to International literature, three criteria are
adopted as a rule for Lucio phenomenon deﬁnition: cutaneous
ulceration, vascular thrombosis, and blood vessel walls inva-
sion by Hansen’s bacillus. The clinical sine qua non criterion
is diffuse non nodular inﬁltration of the skin that has been
compared with myxodema. The prominent inﬁltration of
auricular lobes makes it appear thick and odematous appear-
ance of face makes it appear healthy. This tends to iron out
the wrinkles in the skin of face, restoring a youthful appear-
ance [14,17,23,25] to the older patients. There will not be any
nodule formation. Leprosy bonita/pretty leprosy/Virchowian
Hanseniasis [24–27] refers to the initial loss of wrinkling in
some patients with diffuse disease [20]. In Mexico, the diffuse
variety of leprosy is sometimes called ‘‘pretty leprosy’’. Later
on progression of disease hands become swollen, puffy and
red and legs become edematous. Over time all skin become
ﬂaccid and atrophic, giving an ichthyosiform appearance to
some areas such as the legs [14,23].
There is often madarosis, complete alopecia of eyebrows,
eyelashes and body hair. Inﬁltration of the mucosa leads to
chronic rhinitis with epistaxis, septum perforation and destruc-
tion of the nasal cartilages. The tongue is thickened and there
may be hoarseness. The central portion of the forehead (fron-
talis muscle) is more affected than the lateral portions. This
sign is quite characteristic for leprosy and was ﬁrst described
by Monrad–Krohn. The sensory loss on the forehead can be
quite marked (since the skin is relatively cool) but at the hair-
line, there tends to be an abrupt increase in the sensitivity to
pinprick. The upper incisors become loose and often drop
out [24].
Pretty leprosy 1089A peculiar type of lepra reaction named Lucio’s phenome-
non [27–29] or necrotic erythema occurs which is vasculitis of
vessels especially of the dermohypodermic union and of the
hypodermis. Clinically this vasculitis is represented by well-
shaped erythematous spots, later becoming necrotic with
scabs; ulcerations and scars; affecting in ascending order of
frequency: feet, legs, hands, forearms, thighs, arms and, rarely,
the trunk and face, leaving atrophic and stellar scars [18,19].
They are frequently painful. Rarely it can be fatal [8]. In
advanced cases the skin become atropic like a cigarette paper.
Investigations
The subject usually shows no response to lepromin skin test,
no lepromas but there is diffuse inﬁltration of the whole skin
and is multibacillary [14]. Histopathologically there is wide
inﬁltration by macrophages ﬁlled with acid-fast bacilli, proba-
bly belonging to a particular strain named Mycobacterium
lepromatosis [14,21,22]. Vascular patterns affecting all cutane-
ous vessels are characterized by endothelial proliferation and
marked thickening of vessel walls to the point of obliteration,
Angiogenesis, Vascular ectasia, and Thrombosis [10]. The his-
tological features consistent with Lucio phenomena includes
colonization of endothelial cells by acid fast bacilli, ischemic
epidermal necrois, necrotising vasculitis of the small vessels
of the superﬁcial dermis, endothelial proliferation of the med-
ium sized vessels of the mid dermis with passive venous conges-
tion and neutrophilic inﬁltration [19,23].
The Lab ﬁndings observed in Lucio’s phenomenon are ane-
mia, an elevated erythrocyte sedimentation rate, hypoalbumi-
nemia, hypergammaglobunemia, false positive serological
reactions for syphilis, positive rheumatoid factor, mixed type
cryoglobulins, circulating immune complexes and hypocom-
plementemia (Fig. 2) [31].
Treatment
The systemic manifestations of LP include hepatomegaly,
splenomegaly, fever, arthritis and nephritis. It may cause death
by disseminated intravascular coagulation and/or septicemia.
However it has to be differentiated from erythema nodosum.
There is no speciﬁc treatment for Lucio’s phenomenon. There
are reports that go from balanced meals and local hygiene only
or the use of isolated drugs such as dapsone, clofazimine, tha-
lidomide and multidrug therapy.
Leprosy and humans have a long bitter relationship.
Though it has been plaguing us since at least 2000 BC, we
barely understand it 4000 years later and we are still wrestling
with its legacy of stigmatization. Although Lucio’s phenome-
non is very rare in the Indian subcontinent also we should haveFigure 2 Highly bacilliferous diffuse lepromatous leprosy with
no nodule formation.index of suspicion to diagnose and differentiate it from other
entities. Moreover when a dentist encounters patients with
these facial changes this rare entity should also be considered
in the differential diagnosis. A high level of community infor-
mation and education should be maintained to keep both the
public and health professionals aware of how to recognize
and deal with leprosy cases.References
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